Health Catalyst, Inc.
General ticker "HCAT" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $149.2M (TTM average)
Health Catalyst, Inc. does not follow the US Stock Market performance with the rate: -1.6%.
Estimated limits based on current volatility of 2.7%: low 1.72$, high 1.81$
Factors to consider:
- Total employees count: 1200 (-20.0%) as of 2025
- Top business risk factors: Market competition, Economic downturns and volatility, Operational and conduct risks, Cybersecurity threats, Regulatory and compliance
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.88$, 4.09$]
- 2026-12-31 to 2027-12-31 estimated range: [2.01$, 4.26$]
Financial Metrics affecting the HCAT estimates:
- Positive: with PPE of 12.7 at the end of fiscal year the price was low
- Negative: Operating cash flow per share per price, % of 0.43 <= 2.37
- Positive: -13.52 < Operating profit margin, % of -10.40
- Positive: Investing cash flow per share per price, % of 21.47 > 2.08
- Positive: -6.44 < Industry operating cash flow per share per price (median), % of -1.06
- Positive: -28.70 < Return on assets ratio (scaled to [-100,100]) of -26.15
- Positive: Interest expense per share per price, % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of -0.11 <= 0
- Positive: Inventory ratio change, % of -0.47 <= -0.37
Short-term HCAT quotes
Long-term HCAT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $295.94MM | $306.58MM | $311.14MM |
| Operating Expenses | $422.83MM | $376.39MM | $347.24MM |
| Operating Income | $-126.90MM | $-69.81MM | $-36.10MM |
| Non-Operating Income | $9.11MM | $0.64MM | $-141.15MM |
| R&D Expense | $72.63MM | $57.95MM | $49.77MM |
| Income(Loss) | $-117.79MM | $-69.17MM | $-177.26MM |
| Taxes | $0.36MM | $0.33MM | $0.72MM |
| Net Income(Loss)* | $-118.15MM | $-69.50MM | $-177.97MM |
| Stockholders Equity | $366.92MM | $365.21MM | $245.78MM |
| Assets | $701.81MM | $858.93MM | $502.64MM |
| Operating Cash Flow | $-33.08MM | $14.56MM | $0.73MM |
| Capital expenditure | $14.31MM | $16.40MM | $0.97MM |
| Investing Cash Flow | $20.29MM | $-22.90MM | $36.19MM |
| Financing Cash Flow | $2.73MM | $151.75MM | $-235.78MM |
| Earnings Per Share** | $-2.09 | $-1.15 | $-2.55 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.